The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites

被引:4
|
作者
Kim, Jun Jae [1 ]
Kim, Jeong Han [1 ]
Koo, Ja Kyung [1 ]
Choi, Yun Jung [1 ]
Ko, Soon Young [1 ]
Choe, Won Hyeok [1 ]
Kwon, So Young [1 ]
机构
[1] Konkuk Univ, Sch Med, Digest Dis Ctr, Dept Internal Med, Seoul, South Korea
关键词
End Stage Liver Disease; Liver Cirrhosis; Ascites; Mortality; Hyponatremia;
D O I
10.3350/cmh.2014.20.1.47
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The modification of the Model for End-Stage Liver Disease (MELD) scoring system (Refit MELD) and the modification of MELD-Na (Refit MELDNa), which optimized the MELD coefficients, were published in 2011. We aimed to validate the superiority of the Refit MELDNa over the Refit MELD for the prediction of 3-month mortality in Korean patients with cirrhosis and ascites. Methods: We reviewed the medical records of patients admitted with hepatic cirrhosis and ascites to the Konkuk University Hospital between January 2006 and December 2011. The Refit MELD and Refit MELDNa were compared using the predictive value of the 3-month mortality, as assessed by the Child-Pugh score. Results: In total, 530 patients were enrolled, 87 of whom died within 3 months. Alcohol was the most common etiology of their cirrhosis (n= 271, 51.1%), and the most common cause of death was variceal bleeding (n= 20, 23%). The areas under the receiver operating curve (AUROCs) for the Child-Pugh, Refit MELD, and Refit MELDNa scores were 0.754, 0.791, and 0.764 respectively; the corresponding values when the analysis was performed only in patients with persistent ascites (n= 115) were 0.725, 0.804, and 0.796, respectively. The significant difference found among the Child-Pugh, Refit MELD, and Refit MELDNa scores was between the Child-Pugh score and Refit MELD in patients with persistent ascites (P= 0.039). Conclusions: Refit MELD and Refit MELDNa exhibited good predictability for 3-month mortality in patients with cirrhosis and ascites. However, Refit MELDNa was not found to be a better predictor than Refit MELD, despite the known relationship between hyponatremia and mortality in cirrhotic patients with ascites.
引用
收藏
页码:47 / 55
页数:9
相关论文
共 50 条
  • [21] The model for end-stage liver disease predicts outcomes in patients undergoing cholecystectomy
    Dolejs, Scott C.
    Beane, Joal D.
    Kays, Joshua K.
    Ceppa, Eugene P.
    Zarzaur, Ben L.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2017, 31 (12): : 5192 - 5200
  • [22] A Revised Model for End-Stage Liver Disease Optimizes Prediction of Mortality Among Patients Awaiting Liver Transplantation
    Leise, Michael D.
    Kim, W. Ray
    Kremers, Walter K.
    Larson, Joseph J.
    Benson, Joanne T.
    Therneau, Terry M.
    GASTROENTEROLOGY, 2011, 140 (07) : 1952 - 1960
  • [23] Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond
    Huo, Teh-Ia
    Lee, Shou-Dong
    Lin, Han-Chieh
    LIVER INTERNATIONAL, 2008, 28 (05) : 606 - 613
  • [24] Infections in patients with end-stage liver disease
    Cheruvattath, Rekha
    Balan, Vijayan
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (04) : 403 - 411
  • [25] Liver cirrhosis leads to poorer survival in patients with end-stage renal disease
    Kim, Ae Jin
    Lim, Hye Jin
    Ro, Han
    Jung, Ji Yong
    Lee, Hyun Hee
    Chung, Wookyung
    Chang, Jae Hyun
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (04) : 730 - 738
  • [26] Mortality scoring systems for liver transplant recipients: before and after model for end-stage liver disease score
    Chung, Yang-Hoon
    Jung, Jaewoong
    Kim, Sang Hyun
    ANESTHESIA AND PAIN MEDICINE, 2023, 18 (01): : 21 - 28
  • [27] End-stage liver disease complications
    Rahimi, Robert S.
    Rockey, Don C.
    CURRENT OPINION IN GASTROENTEROLOGY, 2013, 29 (03) : 257 - 263
  • [28] Management of End-stage Liver Disease
    Liou, Iris W.
    MEDICAL CLINICS OF NORTH AMERICA, 2014, 98 (01) : 119 - +
  • [29] Complications of end-stage liver disease
    Perri, Giulia-Anna
    Khosravani, Houman
    CANADIAN FAMILY PHYSICIAN, 2016, 62 (01) : 44 - 50
  • [30] Stage of Cirrhosis Predicts the Risk of Liver-Related Death in Patients With Low Model for End-Stage Liver Disease Scores and Cirrhosis Awaiting Liver Transplantation
    Wedd, Joel
    Bambha, Kiran M.
    Stotts, Matt
    Laskey, Heather
    Colmenero, Jordi
    Gralla, Jane
    Biggins, Scott W.
    LIVER TRANSPLANTATION, 2014, 20 (10) : 1193 - 1201